Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

EnFocus 2300, EnFocus 4400

K-Number: K162783 · 2016-12-09

Decision Date2016-12-09
Product CodeOBO
Advisory CommitteeOP
DecisionSubstantially Equivalent

Device Summary

EnFocus 2300, EnFocus 4400 is the device name listed in this FDA 510(k) record. The listed applicant is Bioptigen, Inc.. It received FDA 510(k) clearance on 2016-12-09 under 510(k) number K162783. The device is classified under product code OBO. It was reviewed by the OP advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the EnFocus 2300, EnFocus 4400?

EnFocus 2300, EnFocus 4400 is a medical device that received FDA 510(k) clearance on 2016-12-09. The listed applicant is Bioptigen, Inc.. The 510(k) number is K162783.

When did EnFocus 2300, EnFocus 4400 receive FDA 510(k) clearance?

EnFocus 2300, EnFocus 4400 received FDA 510(k) clearance on 2016-12-09, under 510(k) number K162783.

Who is the listed applicant for EnFocus 2300, EnFocus 4400?

The FDA 510(k) record lists Bioptigen, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for EnFocus 2300, EnFocus 4400?

The FDA product code for EnFocus 2300, EnFocus 4400 is OBO.

Related Devices (Code: OBO)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.